Summary
The global Nuclear Medicine And Radiopharmaceuticals Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
Nuclear medicine and radiopharmaceuticals are drugs that encompass radioactive isotopes. They are used in various diagnosis and therapeutics for treating cancer and cardiac & neurological disorders.
The rising prevalence of cancer is a prime factor driving the market growth of nuclear medicine and radiopharmaceuticals. According to the World Health Organization, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. Cancer-causing infections, such as hepatitis and human papilloma virus (HPV), are responsible for up to 25% of cancer cases in low- and middle-income countries. Moreover, growing awareness regarding nuclear medicine is expected to open new avenues for the market of nuclear medicine and radiopharmaceuticals. Also, the increasing use of nuclear medicines for lymphoma and bone metastasis is further anticipated to foster market growth.
North America is expected to gain significant growth over the forecast period and this is attributed to the high prevalence of cancer coupled with the increasing spending on the healthcare sector by the government. According to the National Cancer Institute, in January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030.
Key Developments:
- In January 2018, Norgine B.V., a European specialist pharmaceutical company announced the launch of LYMPHOSEEK® (Tc 99m tilmanocept) in Finland and Sweden. LYMPHOSEEK is a radiopharmaceutical used for diagnostic purposes by nuclear medicine specialists and surgeons.
- In June 2019, Jubilant Pharma Limited (the company), has announced that it is integrating its radiopharmaceutical drug development and manufacturing business with its radiopharmacy business into a single global radiopharmaceutical brand called Jubilant Radiopharma.
- In July 2020, Lantheus Holdings has showcased the potential of PyL™ Imaging Agent at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 Annual Meeting
- In November 2017, Siemens Healthineers (Erlangen, Germany) showcased its new computed tomography (CT) scanner portfolio and premium mammography system at the 103rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA)
- In November 2019, Rabat has signed a Memorandum of Understanding (MoU) with the National Center for Energy and Nuclear Science and Technology (CNSTN). The MoU aims to create a strategic partnership (consortium) to contribute to the strengthening of nuclear medical services in Morocco, and to enhance the production processes for radioactive pharmaceuticals.
The Nuclear Medicine And Radiopharmaceuticals Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Nuclear Medicine And Radiopharmaceuticals Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
By the Product Type, the market is primarily segmented into:
- Diagnostic Radioisotopes
- Therapeutic Radioisotopes
By Applications, the market is segmented into:
- Oncology
- Cardiology
- Other
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Nuclear Medicine And Radiopharmaceuticals Market Report:
- To assess the size of the market by value and volume
- Analyze the Nuclear Medicine And Radiopharmaceuticals Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Nuclear Medicine And Radiopharmaceuticals Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Nuclear Medicine And Radiopharmaceuticals Market
The Nuclear Medicine And Radiopharmaceuticals Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Nuclear Medicine And Radiopharmaceuticals Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Contents
Executive Summary
1 Industry Overview of Nuclear Medicine & Radiopharmaceuticals
1.1 Definition of Nuclear Medicine & Radiopharmaceuticals
1.2 Nuclear Medicine & Radiopharmaceuticals Segment by Type
1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Diagnostic Radioisotopes
1.2.3 Therapeutic Radioisotopes
1.3 Nuclear Medicine & Radiopharmaceuticals Segment by Applications
1.3.1 Global Nuclear Medicine & Radiopharmaceuticals Consumption Comparison by Applications (2014-2025)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Nuclear Medicine & Radiopharmaceuticals Overall Market
1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue (2014-2025)
1.4.2 Global Nuclear Medicine & Radiopharmaceuticals Production (2014-2025)
1.4.3 North America Nuclear Medicine & Radiopharmaceuticals Status and Prospect (2014-2025)
1.4.4 Europe Nuclear Medicine & Radiopharmaceuticals Status and Prospect (2014-2025)
1.4.5 China Nuclear Medicine & Radiopharmaceuticals Status and Prospect (2014-2025)
1.4.6 Japan Nuclear Medicine & Radiopharmaceuticals Status and Prospect (2014-2025)
1.4.7 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Status and Prospect (2014-2025)
1.4.8 India Nuclear Medicine & Radiopharmaceuticals Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals
2.3 Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
2.4 Industry Chain Structure of Nuclear Medicine & Radiopharmaceuticals
3 Development and Manufacturing Plants Analysis of Nuclear Medicine & Radiopharmaceuticals
3.1 Capacity and Commercial Production Date
3.2 Global Nuclear Medicine & Radiopharmaceuticals Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Nuclear Medicine & Radiopharmaceuticals
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Nuclear Medicine & Radiopharmaceuticals Production and Capacity Analysis
4.2 Nuclear Medicine & Radiopharmaceuticals Revenue Analysis
4.3 Nuclear Medicine & Radiopharmaceuticals Price Analysis
4.4 Market Concentration Degree
5 Nuclear Medicine & Radiopharmaceuticals Regional Market Analysis
5.1 Nuclear Medicine & Radiopharmaceuticals Production by Regions
5.1.1 Global Nuclear Medicine & Radiopharmaceuticals Production by Regions
5.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Regions
5.2 Nuclear Medicine & Radiopharmaceuticals Consumption by Regions
5.3 North America Nuclear Medicine & Radiopharmaceuticals Market Analysis
5.3.1 North America Nuclear Medicine & Radiopharmaceuticals Production
5.3.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Nuclear Medicine & Radiopharmaceuticals Import and Export
5.4 Europe Nuclear Medicine & Radiopharmaceuticals Market Analysis
5.4.1 Europe Nuclear Medicine & Radiopharmaceuticals Production
5.4.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Nuclear Medicine & Radiopharmaceuticals Import and Export
5.5 China Nuclear Medicine & Radiopharmaceuticals Market Analysis
5.5.1 China Nuclear Medicine & Radiopharmaceuticals Production
5.5.2 China Nuclear Medicine & Radiopharmaceuticals Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Nuclear Medicine & Radiopharmaceuticals Import and Export
5.6 Japan Nuclear Medicine & Radiopharmaceuticals Market Analysis
5.6.1 Japan Nuclear Medicine & Radiopharmaceuticals Production
5.6.2 Japan Nuclear Medicine & Radiopharmaceuticals Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Nuclear Medicine & Radiopharmaceuticals Import and Export
5.7 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Market Analysis
5.7.1 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Production
5.7.2 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Import and Export
5.8 India Nuclear Medicine & Radiopharmaceuticals Market Analysis
5.8.1 India Nuclear Medicine & Radiopharmaceuticals Production
5.8.2 India Nuclear Medicine & Radiopharmaceuticals Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Nuclear Medicine & Radiopharmaceuticals Import and Export
6 Nuclear Medicine & Radiopharmaceuticals Segment Market Analysis (by Type)
6.1 Global Nuclear Medicine & Radiopharmaceuticals Production by Type
6.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type
6.3 Nuclear Medicine & Radiopharmaceuticals Price by Type
7 Nuclear Medicine & Radiopharmaceuticals Segment Market Analysis (by Application)
7.1 Global Nuclear Medicine & Radiopharmaceuticals Consumption by Application
7.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption Market Share by Application (2014-2019)
8 Nuclear Medicine & Radiopharmaceuticals Major Manufacturers Analysis
8.1 Bracco Imaging
8.1.1 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
8.1.2 Bracco Imaging Product Introduction, Application and Specification
8.1.3 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bayer
8.2.1 Bayer Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
8.2.2 Bayer Product Introduction, Application and Specification
8.2.3 Bayer Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Mallinckrodt
8.3.1 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
8.3.2 Mallinckrodt Product Introduction, Application and Specification
8.3.3 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Nordion
8.4.1 Nordion Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
8.4.2 Nordion Product Introduction, Application and Specification
8.4.3 Nordion Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Triad Isotopes
8.5.1 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
8.5.2 Triad Isotopes Product Introduction, Application and Specification
8.5.3 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Lantheus
8.6.1 Lantheus Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
8.6.2 Lantheus Product Introduction, Application and Specification
8.6.3 Lantheus Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 IBA Group
8.7.1 IBA Group Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
8.7.2 IBA Group Product Introduction, Application and Specification
8.7.3 IBA Group Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 GE Healthcare
8.8.1 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
8.8.2 GE Healthcare Product Introduction, Application and Specification
8.8.3 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 China Isotope & Radiation
8.9.1 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
8.9.2 China Isotope & Radiation Product Introduction, Application and Specification
8.9.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Jubilant Pharma
8.10.1 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
8.10.2 Jubilant Pharma Product Introduction, Application and Specification
8.10.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Eli Lilly
8.12 Advanced Accelerator Applications
8.13 SIEMENS
8.14 Dongcheng
8.15 Navidea
9 Development Trend of Analysis of Nuclear Medicine & Radiopharmaceuticals Market
9.1 Global Nuclear Medicine & Radiopharmaceuticals Market Trend Analysis
9.1.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size (Volume and Value) Forecast 2019-2025
9.2 Nuclear Medicine & Radiopharmaceuticals Regional Market Trend
9.2.1 North America Nuclear Medicine & Radiopharmaceuticals Forecast 2019-2025
9.2.2 Europe Nuclear Medicine & Radiopharmaceuticals Forecast 2019-2025
9.2.3 China Nuclear Medicine & Radiopharmaceuticals Forecast 2019-2025
9.2.4 Japan Nuclear Medicine & Radiopharmaceuticals Forecast 2019-2025
9.2.5 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Forecast 2019-2025
9.2.6 India Nuclear Medicine & Radiopharmaceuticals Forecast 2019-2025
9.3 Nuclear Medicine & Radiopharmaceuticals Market Trend (Product Type)
9.4 Nuclear Medicine & Radiopharmaceuticals Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Nuclear Medicine & Radiopharmaceuticals Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Table
List of Tables and Figures
Figure Picture of Nuclear Medicine & Radiopharmaceuticals
Table Global Nuclear Medicine & Radiopharmaceuticals Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Nuclear Medicine & Radiopharmaceuticals Production Market Share by Types in 2018
Figure Diagnostic Radioisotopes Product Picture
Figure Therapeutic Radioisotopes Product Picture
Table Global Nuclear Medicine & Radiopharmaceuticals Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Nuclear Medicine & Radiopharmaceuticals Consumption Market Share by Applications in 2018
Figure Oncology
Figure Cardiology
Figure Other
Figure Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) (2014-2025)
Figure Global Nuclear Medicine & Radiopharmaceuticals Production (K Units) (2014-2025)
Figure North America Nuclear Medicine & Radiopharmaceuticals Market Size (Million USD) (2014-2025)
Figure Europe Nuclear Medicine & Radiopharmaceuticals Market Size (Million USD) (2014-2025)
Figure China Nuclear Medicine & Radiopharmaceuticals Market Size (Million USD) (2014-2025)
Figure Japan Nuclear Medicine & Radiopharmaceuticals Market Size (Million USD) (2014-2025)
Figure Southeast Asia Nuclear Medicine & Radiopharmaceuticals Market Size (Million USD) (2014-2025)
Figure India Nuclear Medicine & Radiopharmaceuticals Market Size (Million USD) (2014-2025)
Table Nuclear Medicine & Radiopharmaceuticals Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals in 2018
Figure Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
Figure Industry Chain Structure of Nuclear Medicine & Radiopharmaceuticals
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Nuclear Medicine & Radiopharmaceuticals Manufacturing Plants Distribution
Table Nuclear Medicine & Radiopharmaceuticals Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Nuclear Medicine & Radiopharmaceuticals Capacity (K Units) of Major Manufacturers (2014-2019)
Table Nuclear Medicine & Radiopharmaceuticals Production (K Units) of Major Manufacturers (2014-2019)
Table Nuclear Medicine & Radiopharmaceuticals Production Market Share of Major Manufacturers (2014-2019)
Figure Nuclear Medicine & Radiopharmaceuticals Production Share by Manufacturers in 2018
Table Nuclear Medicine & Radiopharmaceuticals Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Nuclear Medicine & Radiopharmaceuticals Revenue Market Share of Major Manufacturers (2014-2019)
Figure Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers in 2018
Table Nuclear Medicine & Radiopharmaceuticals Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Nuclear Medicine & Radiopharmaceuticals Production by Regions 2014-2019 (K Units)
Table Global Nuclear Medicine & Radiopharmaceuticals Production Market Share by Regions 2014-2019
Figure Global Nuclear Medicine & Radiopharmaceuticals Production Market Share by Regions in 2018
Table Global Nuclear Medicine & Radiopharmaceuticals Revenue by Regions 2014-2019 (Million USD)
Table Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Regions 2014-2019
Figure Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Regions in 2018
Table Global Nuclear Medicine & Radiopharmaceuticals Consumption by Regions 2014-2019 (K Units)
Table Global Nuclear Medicine & Radiopharmaceuticals Consumption Market Share by Regions 2014-2019
Figure North America Nuclear Medicine & Radiopharmaceuticals Production Growth Rate 2014-2019 (K Units)
Figure North America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table North America Nuclear Medicine & Radiopharmaceuticals Production, Consumption Import and Export (K Units)
Figure Europe Nuclear Medicine & Radiopharmaceuticals Production Growth Rate 2014-2019 (K Units)
Figure Europe Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Nuclear Medicine & Radiopharmaceuticals Production, Consumption Import and Export (K Units)
Figure China Nuclear Medicine & Radiopharmaceuticals Production Growth Rate 2014-2019 (K Units)
Figure China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table China Nuclear Medicine & Radiopharmaceuticals Production, Consumption Import and Export (K Units)
Figure Japan Nuclear Medicine & Radiopharmaceuticals Production Growth Rate 2014-2019 (K Units)
Figure Japan Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Nuclear Medicine & Radiopharmaceuticals Production, Consumption Import and Export (K Units)
Figure Southeast Asia Nuclear Medicine & Radiopharmaceuticals Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Nuclear Medicine & Radiopharmaceuticals Production, Consumption Import and Export (K Units)
Figure India Nuclear Medicine & Radiopharmaceuticals Production Growth Rate 2014-2019 (K Units)
Figure India Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table India Nuclear Medicine & Radiopharmaceuticals Production, Consumption Import and Export (K Units)
Figure Global Consumption Nuclear Medicine & Radiopharmaceuticals Market Share by Application (2014-2019)
Figure Global Value (Consumption) Nuclear Medicine & Radiopharmaceuticals Market Share by Application (2014-2019)
Table Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
Table Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
Table Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Production Growth Rate (2014-2019)
Table Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Production Market Share (2014-2019)
Figure Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Revenue Market Share (2014-2019)
Table Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Main Business and Markets Served
Table Bayer Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
Table Bayer Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
Table Bayer Nuclear Medicine & Radiopharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Nuclear Medicine & Radiopharmaceuticals Production Growth Rate (2014-2019)
Table Bayer Nuclear Medicine & Radiopharmaceuticals Production Market Share (2014-2019)
Figure Bayer Nuclear Medicine & Radiopharmaceuticals Revenue Market Share (2014-2019)
Table Bayer Nuclear Medicine & Radiopharmaceuticals Main Business and Markets Served
Table Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
Table Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
Table Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Production Growth Rate (2014-2019)
Table Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Production Market Share (2014-2019)
Figure Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Revenue Market Share (2014-2019)
Table Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Main Business and Markets Served
Table Nordion Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
Table Nordion Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
Table Nordion Nuclear Medicine & Radiopharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Nordion Nuclear Medicine & Radiopharmaceuticals Production Growth Rate (2014-2019)
Table Nordion Nuclear Medicine & Radiopharmaceuticals Production Market Share (2014-2019)
Figure Nordion Nuclear Medicine & Radiopharmaceuticals Revenue Market Share (2014-2019)
Table Nordion Nuclear Medicine & Radiopharmaceuticals Main Business and Markets Served
Table Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
Table Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
Table Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Production Growth Rate (2014-2019)
Table Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Production Market Share (2014-2019)
Figure Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Revenue Market Share (2014-2019)
Table Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Main Business and Markets Served
Table Lantheus Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
Table Lantheus Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
Table Lantheus Nuclear Medicine & Radiopharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Lantheus Nuclear Medicine & Radiopharmaceuticals Production Growth Rate (2014-2019)
Table Lantheus Nuclear Medicine & Radiopharmaceuticals Production Market Share (2014-2019)
Figure Lantheus Nuclear Medicine & Radiopharmaceuticals Revenue Market Share (2014-2019)
Table Lantheus Nuclear Medicine & Radiopharmaceuticals Main Business and Markets Served
Table IBA Group Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
Table IBA Group Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
Table IBA Group Nuclear Medicine & Radiopharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table IBA Group Nuclear Medicine & Radiopharmaceuticals Production Growth Rate (2014-2019)
Table IBA Group Nuclear Medicine & Radiopharmaceuticals Production Market Share (2014-2019)
Figure IBA Group Nuclear Medicine & Radiopharmaceuticals Revenue Market Share (2014-2019)
Table IBA Group Nuclear Medicine & Radiopharmaceuticals Main Business and Markets Served
Table GE Healthcare Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
Table GE Healthcare Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
Table GE Healthcare Nuclear Medicine & Radiopharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GE Healthcare Nuclear Medicine & Radiopharmaceuticals Production Growth Rate (2014-2019)
Table GE Healthcare Nuclear Medicine & Radiopharmaceuticals Production Market Share (2014-2019)
Figure GE Healthcare Nuclear Medicine & Radiopharmaceuticals Revenue Market Share (2014-2019)
Table GE Healthcare Nuclear Medicine & Radiopharmaceuticals Main Business and Markets Served
Table China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
Table China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
Table China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Production Growth Rate (2014-2019)
Table China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Production Market Share (2014-2019)
Figure China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Revenue Market Share (2014-2019)
Table China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Main Business and Markets Served
Table Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
Table Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Product Introduction, Application and Specification
Table Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Production Growth Rate (2014-2019)
Table Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Production Market Share (2014-2019)
Figure Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Revenue Market Share (2014-2019)
Table Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Main Business and Markets Served
Table Eli Lilly Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
Table Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
Table SIEMENS Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
Table Dongcheng Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
Table Navidea Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
Figure Global Nuclear Medicine & Radiopharmaceuticals Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Nuclear Medicine & Radiopharmaceuticals Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Nuclear Medicine & Radiopharmaceuticals by Type (2019-2025)
Table Global Consumption (K Units) of Nuclear Medicine & Radiopharmaceuticals by Application (2019-2025)
Table Nuclear Medicine & Radiopharmaceuticals Distributors List
Table Nuclear Medicine & Radiopharmaceuticals Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Request Discount 
Inquire Before Buy
